Gary Phillips

Gary Phillips is the current president of the San Diego Tech Coast Angels, an affiliate of the largest angel investor group in the United States. Members of the Tech Coast Angels provide funding and guidance to more early-stage, high-growth companies in Southern California than any other investment group.

Recent posts

Help Save Our Innovation Economy from the SEC’s Rewrite of Reg D
Over the past 30 years, the United States has developed an infrastructure to nurture, grow, and fund early stage companies that is the envy of the world. There are more than... Read more »
Exit Early and Often: A New Age of Limited Options for Entrepreneurs
I rarely meet an entrepreneur (or one of their investors) who doesn’t believe their venture will be a runaway hit. In three to five years, I hear over and over, we’ll... Read more »
How the TCA is Making 2013 The Year of the Angel Investor
A number of pundits have been claiming that angel investment is waning, and that such funding opportunities will remain few and far between for deserving startups seeking to take their innovations... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes

Sponsored · Whitepaper
What to Include in Your Life Sciences Company Fundraising Pitch Deck
What the most successful life sciences fundraising pitch decks all have in common
Brex

Sponsored · Webinar
Screening Approaches for Reducing Attrition Due to Drug-induced Liver Injury (DILI) Early in Drug Discovery
In vitro assays that tackle the challenges of in vitro hepatotoxicity assessment
Eurofins Discovery

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem's Approval & More

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

BARDA Director Rick Bright Moves to NIH to Head COVID-19 Testing R&D

Lantern Pharma IPO File Illuminates Plan to “Rescue” Failed Cancer Drugs

RDMD Lands $14M to Expand Reach of Rare Disease Research Platform

Xcelerating Life Sciences Philadelphia (interactive online event)

Xcelerating Life Sciences San Francisco (interactive online event)

Xcelerating Life Sciences Seattle

Gary Phillips

Recent posts

Help Save Our Innovation Economy from the SEC’s Rewrite of Reg D

Exit Early and Often: A New Age of Limited Options for Entrepreneurs

How the TCA is Making 2013 The Year of the Angel Investor

Underwriters and Partners

How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook

What to Include in Your Life Sciences Company Fundraising Pitch Deck

Screening Approaches for Reducing Attrition Due to Drug-induced Liver Injury (DILI) Early in Drug Discovery

Xconomy on Demand

We offer a number of ways to subscribe for free!